Skin and Mucosal Delivery (Focus Group – SMD)
Alisher Djumaev, MSc
PhD Student
De Montfort University
Leicester, England, United Kingdom
Traditional parenteral vaccination has several limitations, including invasiveness, the risk of needle injury, and strict cold chain requirements. Transdermal microneedle (MN) vaccination is a painless alternative targeting immunocompetent skin layers1. This research aims to develop an innovative "core-shell" MN system for antigen delivery. By utilizing self-assembling peptide hydrogels as a core matrix, sensitive protein subunit antigens can be stabilized and delivered through optimized polymeric shells2,3.